These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 24794971)

  • 1. Eliciting antibiotics active against the ESKAPE pathogens in a collection of actinomycetes isolated from mountain soils.
    Zhu H; Swierstra J; Wu C; Girard G; Choi YH; van Wamel W; Sandiford SK; van Wezel GP
    Microbiology (Reading); 2014 Aug; 160(Pt 8):1714-1725. PubMed ID: 24794971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro Screening of an FDA-Approved Library Against ESKAPE Pathogens.
    Younis W; AbdelKhalek A; Mayhoub AS; Seleem MN
    Curr Pharm Des; 2017; 23(14):2147-2157. PubMed ID: 28190396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternatives for the treatment of infections caused by ESKAPE pathogens.
    da Rosa TF; Coelho SS; Foletto VS; Bottega A; Serafin MB; Machado CS; Franco LN; de Paula BR; Hörner R
    J Clin Pharm Ther; 2020 Aug; 45(4):863-873. PubMed ID: 32339305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
    Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dramatic increase in antimicrobial resistance in ESKAPE clinical isolates over the 2010-2020 decade in India.
    Kharat AS; Makwana N; Nasser M; Gayen S; Yadav B; Kumar D; Veeraraghavan B; Mercier C
    Int J Antimicrob Agents; 2024 May; 63(5):107125. PubMed ID: 38431109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential anti-microbial secondary metabolites in different ESKAPE pathogens explain their adaptation in the hospital setup.
    Tiwari V; Meena K; Tiwari M
    Infect Genet Evol; 2018 Dec; 66():57-65. PubMed ID: 30227225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vitro Emergence of High Persistence upon Periodic Aminoglycoside Challenge in the ESKAPE Pathogens.
    Michiels JE; Van den Bergh B; Verstraeten N; Fauvart M; Michiels J
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4630-7. PubMed ID: 27185802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Navigating ESKAPE Pathogens: Considerations and Caveats for Animal Infection Models Development.
    Yu H; Xu Y; Imani S; Zhao Z; Ullah S; Wang Q
    ACS Infect Dis; 2024 Jul; 10(7):2336-2355. PubMed ID: 38866389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on the main MDR pathogens: prevalence and treatment options.
    Esposito S; De Simone G
    Infez Med; 2017 Dec; 25(4):301-310. PubMed ID: 29286008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial activity of Actinobacteria isolated from dry land soil in Yazd, Iran.
    Majidzadeh M; Heidarieh P; Fatahi-Bafghi M; Vakili M
    Mol Biol Rep; 2021 Feb; 48(2):1717-1723. PubMed ID: 33599952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Norfloxacin salts of carboxylic acids curtail planktonic and biofilm mode of growth in ESKAPE pathogens.
    Lowrence RC; Ramakrishnan A; Sundaramoorthy NS; Shyam A; Mohan V; Subbarao HMV; Ulaganathan V; Raman T; Solomon A; Nagarajan S
    J Appl Microbiol; 2018 Feb; 124(2):408-422. PubMed ID: 29178633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of backbone-aminated analogues of gramicidin S.
    Rathman BM; Allen JL; Shaw LN; Del Valle JR
    Bioorg Med Chem Lett; 2020 Aug; 30(15):127283. PubMed ID: 32527462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial potential of Halophilic actinomycetes against multi drug resistant (MDR) ventilator associated pneumonia causing bacterial pathogens.
    Aslam S; Sajid I
    Pak J Pharm Sci; 2016 Mar; 29(2):367-74. PubMed ID: 27087086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paradoxical Effect of Polymyxin B: High Drug Exposure Amplifies Resistance in Acinetobacter baumannii.
    Tsuji BT; Landersdorfer CB; Lenhard JR; Cheah SE; Thamlikitkul V; Rao GG; Holden PN; Forrest A; Bulitta JB; Nation RL; Li J
    Antimicrob Agents Chemother; 2016 Jul; 60(7):3913-20. PubMed ID: 27067330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics.
    Miller WR; Arias CA
    Nat Rev Microbiol; 2024 Oct; 22(10):598-616. PubMed ID: 38831030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of silver nanoparticles synthesized by acidophilic strain of Actinobacteria isolated from the of Picea sitchensis forest soil.
    Railean-Plugaru V; Pomastowski P; Wypij M; Szultka-Mlynska M; Rafinska K; Golinska P; Dahm H; Buszewski B
    J Appl Microbiol; 2016 May; 120(5):1250-63. PubMed ID: 26864807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmid profiles among some ESKAPE pathogens in a tertiary care centre in south India.
    Ragupathi NKD; Bakthavatchalam YD; Mathur P; Pragasam AK; Walia K; Ohri VC; Veeraraghavan B
    Indian J Med Res; 2019 Feb; 149(2):222-231. PubMed ID: 31219087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The therapeutic potential of indole hybrids, dimers, and trimers against drug-resistant ESKAPE pathogens.
    Qiongxian Y; Jun D; Zhenfeng Z; Tongyou L; Zhicong T; Zhenyou T
    Arch Pharm (Weinheim); 2024 Oct; 357(10):e2400295. PubMed ID: 38924571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of multidrug-resistant bacteria at a tertiary-care teaching hospital in Mexico: special focus on Acinetobacter baumannii.
    Garza-González E; Llaca-Díaz JM; Bosques-Padilla FJ; González GM
    Chemotherapy; 2010; 56(4):275-9. PubMed ID: 20693798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
    Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.